WIPO

Cepheid Tuberculosis Assay Receives WHO Prequalification

VA Offering No-Cost PGx Testing Through End of 2025

GeneDx Launches Program to Boost Access to Exome Testing for Pediatric Epilepsy Patients

LGC Acquires German Quality Controls Maker DiaMex

Point-of-Care Testing Firm 52North Closes $6M Financing Round

Lucid Diagnostics Raises $22M in Convertible Debt Refinancing